Gene sequencing of the blood revealed an EGFR kinase domain duplication (EGFR-KDD mutation) that has not previously been reported as an acquired mutation due to EGFR-TKI resistance in NSCLC [19]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.